share_log

万泰生物(603392.SH):公司九价HPV疫苗暂无分段生产的计划

Beijing Wantai Biological Pharmacy Enterprise (603392.SH): The company currently has no plans to produce the non-segmented HPV vaccine.

Gelonghui Finance ·  Nov 7, 2024 00:49

Gelonghui November 7th | Beijing Wantai Biological Pharmacy Enterprise (603392.SH) stated on the interactive platform that the company has no plans for segmented production of the nine-valent HPV vaccine.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment